Cubist Systematic Strategies »

Adaptimmune Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2023-12-31 $27k 35k 0.79
2023-06-30 $9.3k 10k 0.93
2023-03-31 $14k 13k 1.09
2022-12-31 $33k 23k 1.46
2022-06-30 $4.0k 2.1k 1.91
2022-03-31 $91k 44k 2.06
2021-12-31 $302k 81k 3.75
2021-09-30 $300k 58k 5.18
2021-06-30 $42k 9.9k 4.24
2021-03-31 $22k 4.2k 5.24
2020-12-31 $117k 22k 5.40
2020-06-30 $198k 20k 10.03
2018-12-31 $88k 15k 5.78
2018-09-30 $159k 12k 13.54
2018-06-30 $241k 20k 11.85
2018-03-31 $254k 23k 11.23
2017-12-31 $129k 19k 6.66
2017-09-30 $182k 22k 8.21
2017-03-31 $7.0k 1.2k 5.83
2015-12-31 $0 7 0.00